The National Alzheimer's Project Act (NAPA) creates an important opportunity to build upon and leverage HHS programs and other federal efforts to help change the trajectory of Alzheimer's disease and related dementias (AD/ADRD). The law calls for a National Plan for AD/ADRD with input from a public-private Advisory Council on Alzheimer's Research, Care and Services. The Advisory Council makes recommendations to HHS for priority actions to expand, coordinate, and condense programs in order to improve the health outcomes of people with AD/ADRD and reduce the financial burden of these conditions on those with the diseases, their families, and society.
In order to inform the National Plan for AD/ADRD, HHS has partnered with the U.S. Department of Veterans Affairs (VA), the National Science Foundation (NSF), and the U.S. Department of Defense (DoD) to convene an Interagency Group on Alzheimer's Disease and Related Dementias. The group includes HHS representatives from the Office of the Assistant Secretary for Planning and Evaluation (ASPE), Office of the Assistant Secretary for Health (OASH), National Institute on Aging (NIA), Centers for Medicare and Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Administration on Aging (AoA), Health Resources and Services Administration (HRSA), Agency for Healthcare Research and Quality (AHRQ), Substance Abuse and Mental Health Services Administration (SAMHSA), Food and Drug Administration (FDA), Indian Health Service (IHS), and Administration for Children and Families (ACF). The Interagency Group is working to carry out NAPA's charges to coordinate research and services across agencies, accelerate the development of AD/ADRD treatments, improve early diagnosis and coordination of care, reduce ethnic and racial disparities in rates of AD/ADRD, and coordinate with international efforts to fight these conditions. The Plan this group developed was presented to the Advisory Council for review, and updated annually.
Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.
What's New:
-
February 2017 Advisory Council Meeting Material (added January 2017)
-
ADRD Summit 2016 Report to the National Advisory Neurological Disorders and Stroke Council (added December 2016)
-
Alzheimer's Disease-Related Dementias (ADRD) Summit 2016 -- Prioritized Research Milestones (added December 2016)
-
Alzstream Webinar: Dialogue with the National Institutes of Health on Alzheimer's Disease (added December 2016)
-
National Plan to Address Alzheimer's Disease: 2016 Update (added August 2016)
-
Public Members of the Advisory Council on Alzheimer's Research, Care, and Services: 2016 Recommendations (added August 2016)
Find Information On:
What is Alzheimer's Disease & Related Dementias |
Advisory Council on Alzheimer's Research, Care, & Services |
National Plan & Other NAPA Documents |
Other Information on AD/ADRD |
| Including: - Advisory Council Members - Meeting Material - Public Comments |
Including: - National Plans - Council Recommendations - Research Milestones - Frequently Used Acronyms - General Information |
Including: - Agency Reports - Agency Meetings - Agency Websites |
|
WOULD YOU LIKE TO BE ALERTED WHEN NEW INFORMATION IS AVAILABLE? A Listserv is also available that will automatically email you a monthly message. To join, send an email to LISTSERV@LIST.NIH.GOV. Whatever email address the message is sent from will be what is used in the Listserv. The only thing that needs to be in the body of the message is: subscribe NAPA-L your name |
